CURE vs. LINT

Last updated Jun 24, 2026

CURE (Direxion Daily Healthcare Bull 3x Shares) and LINT (Direxion Daily INTC Bull 2X Shares) are both Leveraged Equities funds from Direxion. CURE is passively managed, while LINT is actively managed. At a 0.11 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 0.97%/yr for LINT.

Performance

CURE vs. LINT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily INTC Bull 2X Shares (LINT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CURE achieves a -10.45% return, which is significantly lower than LINT's 744.89% return.

CURE

• 1D: 3.78%
• 1M: 4.14%
• YTD: -10.45%
• 6M: -10.93%
• 1Y: 35.07%
• 3Y*: 1.46%
• 5Y*: 0.46%
• 10Y*: 14.03%

LINT

• 1D: -12.86%
• 1M: 11.99%
• YTD: 744.89%
• 6M: 773.46%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. LINT - Yearly Performance Comparison

	2026 (YTD)	2025
CURE Direxion Daily Healthcare Bull 3x Shares	-10.45%	3.86%
LINT Direxion Daily INTC Bull 2X Shares	744.89%	5.81%

Correlation

The correlation between CURE and LINT is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Nov 19, 2025	0.11

CURE vs. LINT - Sectors Allocation Comparison

Sectors	CURE	LINT
Healthcare	100.0%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	100.0%
Utilities	-	-

Return for Risk

CURE vs. LINT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE

CURE Risk / Return Rank: 24
CURE Sharpe Ratio Rank: 23
CURE Sortino Ratio Rank: 27
CURE Omega Ratio Rank: 24
CURE Calmar Ratio Rank: 24
CURE Martin Ratio Rank: 22

LINT

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. LINT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily INTC Bull 2X Shares (LINT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CURE	LINT	Difference
Sharpe ratio: Return per unit of total volatility	0.79	—	—
Sortino ratio: Return per unit of downside risk	1.42	—	—
Omega ratio: Gain probability vs. loss probability	1.16	—	—
Calmar ratio: Return relative to maximum drawdown	1.13	—	—
Martin ratio: Return relative to average drawdown	2.51	—	—

Drawdowns

CURE vs. LINT - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, which is greater than LINT's maximum drawdown of -49.54%. Use the drawdown chart below to compare losses from any high point for CURE and LINT.

Drawdown Indicators

	CURE	LINT	Difference
Max Drawdown Largest peak-to-trough decline	-69.19%	-49.54%	-19.65%
Max Drawdown (1Y) Largest decline over 1 year	-31.10%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-51.93%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-52.23%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-69.19%	—	—
Current Drawdown Current decline from peak	-28.92%	-12.86%	-16.06%
Average Drawdown Average peak-to-trough decline	-18.18%	-20.48%	+2.30%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.98%	—	—

Volatility

Volatility by Period

	CURE	LINT	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.41%	—	—
Volatility (6M) Calculated over the trailing 6-month period	31.09%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	44.49%	168.83%	-124.34%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.92%	168.83%	-124.91%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	49.58%	168.83%	-119.25%

CURE vs. LINT - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than LINT's 0.97% expense ratio.

Dividends

CURE vs. LINT - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.19%, more than LINT's 0.10% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
CURE Direxion Daily Healthcare Bull 3x Shares	1.19%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%
LINT Direxion Daily INTC Bull 2X Shares	0.10%	0.25%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both CURE and LINT in my portfolio?

CURE and LINT have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, CURE or LINT?

On fees, LINT is cheaper at 0.97% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CURE or LINT?

LINT is cheaper with a 0.97% expense ratio, compared with 1.08% for CURE.

Which ETF pays a higher dividend yield, CURE or LINT?

CURE has the higher dividend yield at 1.19%, compared with 0.10% for LINT.

What is the main difference between CURE and LINT?

Their fees differ too: 1.08% for CURE and 0.97% for LINT.